Aktiia

Aktiia

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $47.5M

Overview

Aktiia is a pioneering medical device company that has developed the first CE-marked, cuffless blood pressure monitor for 24/7 automated measurement. Its core technology, based on optical sensors and proprietary algorithms, has been validated in multiple clinical trials published in peer-reviewed journals like Nature. The company is commercializing its Class IIa medical device across Europe, targeting both consumer health and clinical research markets with a data-driven approach to hypertension management.

Cardiovascular DiseaseHypertension

Technology Platform

Optical Blood Pressure Monitoring (OBPM™) platform using a wearable device with photoplethysmography (PPG) sensors and proprietary algorithms to enable cuffless, automated, 24/7 blood pressure measurement.

Funding History

2
Total raised:$47.5M
Series B$30M
Series A$17.5M

Opportunities

The global shift towards remote patient monitoring and value-based care creates a massive opportunity for convenient, continuous blood pressure data.
Aktiia's clinically validated platform can disrupt the cumbersome ambulatory blood pressure monitor (ABPM) market and enable new data-driven hypertension management services for healthcare providers and payers.

Risk Factors

Key risks include intense competition from large tech and medtech companies entering the cuffless monitoring space, the challenge and cost of obtaining FDA clearance for the US market, and the need to secure healthcare reimbursement to drive widespread clinical adoption beyond direct-to-consumer sales.

Competitive Landscape

Aktiia competes with traditional home BP monitor companies (Omron, Withings), ambulatory BP monitor providers, and a growing field of tech companies developing cuffless optical sensing (e.g., Apple, Samsung). Its primary competitive advantage is its early CE Mark as a Class IIa device and strong publication record in peer-reviewed journals validating clinical accuracy.